- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Antiretroviral Rx
Question | Discussion | References | CME Credit
Updated September 29, 2012
Case 2: Antiretroviral Regimens
| Author: | David H. Spach, MD |
- Identify the key enzymes involved in the HIV life cycle.
- List the preferred antiretroviral regimens as recommended in the HHS antiretroviral therapy guidelines for persons with chronic HIV infection.
A 36-year-old woman has recently been diagnosed with HIV infection. Her initial laboratory studies show a CD4 count of 100 cells/mm3 and HIV RNA of 87,500 copies/ml. Repeat laboratory studies performed one month later show similar results. She has not had any HIV-related complications history. Her physical examination is normal. She is very interested in starting antiretroviral therapy. Her only medication that she takes is trimethoprim-sulfamethoxazole (Bactrim, Septra).
According to the 2012 HHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents, which of the following is considerd a preferred initial combination regimen for antiretroviral-naive patients?
Copyright © 2004-2013 University of Washington